Loading...

AbbVie

 

The Evolution in Treatment of Brain Tumours – Neuro-Oncology in the Age of Precision Medicine

Date: Sunday, June 23
Time: 0730-0830
Room: Strategy 3, Sheraton on the Falls Hotel

Last Name
First Name
Organization
Email
Yes!

THE EVOLUTION IN TREATMENT OF BRAIN TUMOURS: NEURO‑ONCOLOGY IN THE AGE OF PRECISION MEDICINE

We are honoured to invite you to attend AbbVie’s Satellite Symposium during the 70th Annual Meeting of the Canadian Association of Pathologists.

Mark Sunday, June 23, 2019, on your calendar and join your esteemed colleagues for a morning of future discovery.

Date: Sunday, June 23, 2019

Location: Sheraton, Niagara Falls

Time: From 7:30 AM to 8:30 AM (complimentary breakfast will be served from 7:15 AM onwards)

RSVP: Please register by clicking below.

SPEAKERS

Dr. Nada Jabado, PhD, MD

  • Professor of Pediatrics, McGill University
  • Pediatric Neuro-oncologist, Montreal Children’s Hospital

Dr. Marie-Christine Guiot, MD

  • Associate Professor, McGill University
  • Collaborator,
    • Departments of Pathology, Neurology and Neurosurgery, Montreal Neurological Institute
    • Goodman Cancer Research Centre at McGill University

Dr. Arjun Sahgal, MD, FRCPC

  • Deputy Chief, Department of Radiation Oncology, Odette Cancer Centre – Sunnybrook Health Sciences Centre
  • Director, Sunnybrook Cancer Ablation Therapy (CAT) Program

Dr. Sunit Das, PhD, MD

  • Neurosurgeon and Scientist,
    • St. Michael’s Hospital
    • Research Institute of the Hospital for Sick Children (SickKids®)
  • Associate Professor, Department of Surgery, University of Toronto

LEARNING OBJECTIVES

At the end of this symposium, participants will be able to:
  • Evaluate the role of new molecular biomarkers and the emerging role for targeted therapy in glioma
  • Discuss the management of tissue for biomarker evaluation in glioma
  • Understand the differences between new modalities for radiation therapy (ex. IMRT, hypofractionation)
  • Comprehend the importance of the multidisciplinary team for delivering personalized care for patients with intracranial neoplasms

This symposium has been planned and developed to achieve scientific integrity, objectivity and balance. This program is financially sponsored by AbbVie.

abbvie